JinY.RobertsGHL.FerraraTMet al. Early-onset autoimmune vitiligo associated with an enhancer variant haplotype that upregulates class II HLA expression. Nat Commun. 2019;10(1):391.doi:10.1038/s41467-019-08337-430674883
2.
KimHS.KimHJ.HongESet al. The incidence and survival of melanoma and nonmelanoma skin cancer in patients with vitiligo: a nationwide population-based matched cohort study in Korea. Br J Dermatol. 2020;182(4):907-915.doi:10.1111/bjd.1824731233609
3.
RassenJA.BartelsDB.SchneeweissS.PatrickAR.MurkW. Measuring prevalence and incidence of chronic conditions in claims and electronic health record databases. Clin Epidemiol. 2019;11:1-15.doi:10.2147/CLEP.S18124230588119
4.
BaeJM.ChungKY.YunSJet al. Markedly reduced risk of internal malignancies in patients with vitiligo: a nationwide population-based cohort study. J Clin Oncol. 2019;37(11):903-911.doi:10.1200/JCO.18.0122330785828
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
